GDF2 and atherosclerosis: Conversely, treatment of EC with BMP-9 markedly reduces LDL transcytosis in an ALK-1–dependent manner, implying that the levels of BMP-9 may regulate LDL transcytosis and ultimately the extent of atherosclerosis.